Zhanxia Li

478 total citations
14 papers, 381 citations indexed

About

Zhanxia Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Zhanxia Li has authored 14 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Zhanxia Li's work include RNA modifications and cancer (3 papers), Cancer Mechanisms and Therapy (2 papers) and Protein Hydrolysis and Bioactive Peptides (2 papers). Zhanxia Li is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer Mechanisms and Therapy (2 papers) and Protein Hydrolysis and Bioactive Peptides (2 papers). Zhanxia Li collaborates with scholars based in China, Saudi Arabia and Italy. Zhanxia Li's co-authors include Chi Liu, Yi Sheng, Ming Luo, Dongyi Zhu, Tao Ren, Qingchun Lu, Wenjing Jin, Yang Han, Shan Shan and Li Gu and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Frontiers in Microbiology.

In The Last Decade

Zhanxia Li

13 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhanxia Li China 8 300 107 84 54 46 14 381
Min Gong China 12 329 1.1× 57 0.5× 69 0.8× 66 1.2× 45 1.0× 23 442
Yijie Yang China 11 234 0.8× 20 0.2× 52 0.6× 49 0.9× 36 0.8× 22 396
Joanne Maycock United Kingdom 10 244 0.8× 24 0.2× 41 0.5× 26 0.5× 17 0.4× 16 400
Melanie Martin Germany 12 251 0.8× 13 0.1× 66 0.8× 75 1.4× 28 0.6× 21 387
Ana Conchillo Spain 10 222 0.7× 38 0.4× 14 0.2× 19 0.4× 105 2.3× 18 437
Paul Chukwudi Ikwegbue South Africa 6 158 0.5× 33 0.3× 23 0.3× 45 0.8× 14 0.3× 8 332
Tae-Kyu Park South Korea 13 277 0.9× 30 0.3× 24 0.3× 50 0.9× 5 0.1× 34 471
Yongjiang Ma China 13 250 0.8× 198 1.9× 15 0.2× 34 0.6× 31 0.7× 30 493
Tzu-Yuan Wang Taiwan 10 201 0.7× 8 0.1× 54 0.6× 45 0.8× 36 0.8× 21 301
Zhigui Wu China 14 235 0.8× 72 0.7× 40 0.5× 19 0.4× 4 0.1× 29 435

Countries citing papers authored by Zhanxia Li

Since Specialization
Citations

This map shows the geographic impact of Zhanxia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanxia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanxia Li more than expected).

Fields of papers citing papers by Zhanxia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanxia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanxia Li. The network helps show where Zhanxia Li may publish in the future.

Co-authorship network of co-authors of Zhanxia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanxia Li. A scholar is included among the top collaborators of Zhanxia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanxia Li. Zhanxia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hussain, Muhammad Hammad, Lu Han, Muhammad Arshad Javid, et al.. (2025). Rational engineering of Escherichia coli strain for stable and enhanced biosynthesis of pinene. Frontiers in Microbiology. 15. 1527113–1527113.
2.
Liu, Yu, Kamran Ashraf, Zhanxia Li, et al.. (2025). Light-activated multimodal nanoplatform for enhanced synergistic therapy of breast cancer. Scientific Reports. 15(1). 25995–25995. 1 indexed citations
3.
Shan, Shan, Zeyu Liu, Shaoyang Wang, et al.. (2024). Isovalerylspiramycin I suppresses small cell lung cancer proliferation via ATR/CHK1 mediated DNA damage response and PERK/eIF2α/ATF4/CHOP mediated ER stress. Biochemical Pharmacology. 230(Pt 1). 116557–116557. 3 indexed citations
4.
Wang, Bo, Ge Zhang, Yu‐Wen Hu, et al.. (2024). Uncovering impaired mitochondrial and lysosomal function in adipose-derived stem cells from obese individuals with altered biological activity. Stem Cell Research & Therapy. 15(1). 12–12. 8 indexed citations
5.
Zhao, Xueli, Muhammad Hammad Hussain, Ali Mohsin, et al.. (2024). Mechanistic insight for improving butenyl-spinosyn production through combined ARTP/UV mutagenesis and ribosome engineering in Saccharopolyspora pogona. Frontiers in Bioengineering and Biotechnology. 11. 1329859–1329859. 11 indexed citations
6.
Liu, Zeyu, et al.. (2022). Heterogeneous expression of ACE2, TMPRSS2, and FURIN at single-cell resolution in advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 149(7). 3563–3573. 6 indexed citations
7.
Zhu, Dongyi, Li Gu, Zhanxia Li, et al.. (2019). MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2. Pathology - Research and Practice. 215(5). 861–872. 43 indexed citations
8.
Yin, Qi, Yang Han, Dongyi Zhu, et al.. (2018). miR-145 and miR-497 suppress TGF-β-induced epithelial–mesenchymal transition of non-small cell lung cancer by targeting MTDH. Cancer Cell International. 18(1). 105–105. 44 indexed citations
9.
Li, Zhanxia, et al.. (2018). Lnc-SNHG1 may promote the progression of non-small cell lung cancer by acting as a sponge of miR-497. Biochemical and Biophysical Research Communications. 506(3). 632–640. 35 indexed citations
10.
11.
Wang, Xuebin, et al.. (2014). Effects and Mechanism Analysis of Combined Infusion by Levosimendan and Vasopressin on Acute Lung Injury in Rats Septic Shock. Cell Biochemistry and Biophysics. 70(3). 1639–1645. 8 indexed citations
12.
Luo, Ming, Yi Shen, Chi Liu, et al.. (2011). Long-Term Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitory Peptide LAP. Kidney & Blood Pressure Research. 34(5). 358–364. 4 indexed citations
13.
Li, Zhanxia, Songwen Zhou, Ling Zhang, et al.. (2010). BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer. Medical Oncology. 28(2). 572–577. 13 indexed citations
14.
Luo, Ming, et al.. (2008). The antihypertensive effect of peptides: A novel alternative to drugs?. Peptides. 29(6). 1062–1071. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min Gong Breakdown of academic impact, for papers by Yijie Yang Breakdown of academic impact, for papers by Joanne Maycock Breakdown of academic impact, for papers by Melanie Martin Breakdown of academic impact, for papers by Ana Conchillo Breakdown of academic impact, for papers by Paul Chukwudi Ikwegbue Breakdown of academic impact, for papers by Tae-Kyu Park Breakdown of academic impact, for papers by Yongjiang Ma Breakdown of academic impact, for papers by Tzu-Yuan Wang Breakdown of academic impact, for papers by Zhigui Wu
Rankless by CCL
2026